Respuesta: la retatrutida se inyecta por va subcutnea (bajo la piel)
Insulin lowers it, while glucagon raises it by telling the liver to release stored sugar
The maximum dose produces the highest average weight loss in clinical trials, but individual results vary
Distinct from prior reviews that predominantly focus on a single drug class or limited clinical indications, this article systematically contrasts the mechanistic pathways, therapeutic efficacy, and safety profiles of GLP-1RAs versus GLP-1/GIP dual receptor agonists
In clinical studies, volunteers in the higher dose groups such as 8 mg or 12 mg experienced reductions in body weight and waist circumference, up to 19.2% at week 48
A phase 2 randomised controlled trial of mazdutide in Chinese overweight adults or adults with obesity